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Stent graft repair of visceral artery aneurysms
Robert A. Larson, MD,a Jeffrey Solomon, MD,b and Jeffrey P. Carpenter, MD,a Philadelphia, Pa
Endovascular techniques with coil embolization have been used in certain visceral aneurysm cases, often resulting in
sacrifice of the involved visceral vessel and end-organ thrombosis. We describe two cases in which stent grafts were used
to treat these aneurysms, allowing preservation of visceral artery and end-organ flow while completely excluding the
aneurysm. Case 1 was a 50-year-old morbidly obese woman with a history of multiple abdominal operations for renal cell
carcinoma who was found to have a large splenic artery aneurysm. A 12-mm 50-mm Wallgraft endoprosthesis (Boston
Scientific, Watertown, Mass) was placed across the aneurysm from a femoral approach. The aneurysm was completely
excluded, and splenic artery flow was preserved. A subsequent computed tomographic scan showed complete aneurysm
exclusion and preserved flow to the spleen. Case 2 was a 73-year-old man with hypertension with back pain who was
found with computed tomographic scan to have an 8-cm hepatic artery aneurysm. Arteriography showed a large saccular
aneurysm arising from the mid portion of the common hepatic artery. Two 5-mm 26-mm Jostent stent grafts (Jomed,
Alpharetta, Ga) were placed across the aneurysm neck, completely excluding the aneurysm and preserving hepatic artery
flow. The patient became pain free, and subsequent duplex ultrasound scan showed a thrombosed aneurysm with normal
hepatic artery flow. Stent graft techniques show early promise as a safe and effective treatment of visceral artery aneurysms
in selected patients at high risk. Endografts, unlike coil embolization, exclude the aneurysm and preserve end organ
perfusion. Determining the durability of this type of therapy will require further study. (J Vasc Surg 2002;36:1260-3.)
Visceral artery aneurysms (VAAs) are rare but poten-
tially life threatening. The incidence rate has been shown to
be between 0.01% and 0.2% in routine autopsy series, but
more cases are being detected in asymptomatic patients
because of the increasing use of computed tomographic
(CT) scan, abdominal ultrasound scan, and other imaging
methods.1 Traditional therapy has been surgical resection
or ligation2 or endovascular embolization.3 We describe
two cases of visceral artery aneurysms that were treated with
endovascular stent grafts to exclude the aneurysm from the
circulation while preserving end-organ perfusion.
CASE REPORTS
Case 1. A 50-year-old asymptomatic postmenopausal woman
with a history of bilateral renal cell carcinoma was found to have a
20-mm splenic artery aneurysm (SAA) on a follow-up CT scan (Fig
1). Her medical history was remarkable for a left radical nephrec-
tomy, right partial nephrectomy, ventral hernia repair, uterine
artery embolization for fibroids, C-section, hypertension, mitral
valve prolapse, and obesity.
On physical examination, the patient was 5 ft 5 in tall and
weighed 290 lbs. Her abdomen was nontender with multiple
healed scars. The femoral and pedal pulses were normal. The serum
creatinine level was 0.9 mg/dL, and the electrolyte and complete
blood cell counts were normal.
The patient’s comorbidities were believed to make the risk of
open surgical repair greater than the risk of rupture of a 20-mm
SAA. However, the risk of death from a ruptured SAA would also
be great. Therefore, an endovascular approach was chosen, allow-
ing for repair of the aneurysm with an acceptably low procedural
risk.
The procedure was performed in the operating room with
local anesthesia with sedation. An angiographic c-arm with road-
mapping capability was used for radiographic imaging. With fem-
oral access, the celiac artery was selected with a Sos-omni catheter
(AngioDynamics, Inc, Queensbury, NY) and the splenic artery was
selected with a Glide wire (Boston Scientific, Watertown, Mass).
After the patient had been given 5000 units of heparin intrave-
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Fig 1. Abdominal CT scan showing calcified SAA.
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nously, the glide wire was exchanged via a catheter for Lunderquist
wire (Cook, Inc, Bloomington, Ind). Over this wire, a 30 cm–long
12F sheath (Cook, Inc) was advanced to the ostium of the celiac
artery. A roadmap arteriogram was performed through the sheath
that showed the SAA to be partially thrombosed. Its location was
confirmed to be in the mid portion of the splenic artery by the
position of the SAA calcification. A 12-mm  50-mm Wallgraft
endoprosthesis (Boston Scientific) then was advanced into position
and deployed centered on the SAA. A completion celiac arterio-
gram showed patency of the hepatic, left gastric, and splenic
arteries (Fig 2). The stent graft was in good position in the mid
portion of the splenic artery. The heparin was reversed with pro-
tamine, and the groin sheath was removed in the recovery room.
The patient had a small groin hematoma develop after surgery that
was controlled with local compression. She was discharged on the
second postoperative day.
A follow-up CT scan was obtained 1 year after surgery and
showed continued patency of the splenic artery with successful
exclusion of the SAA and no change in the SAA size. The patient
continues to do well.
Case 2. A 73-year-old man was evaluated for back pain with
CT scan at a local hospital. This scan showed a 5.5-cm  8.0-cm
hepatic artery aneurysm (Fig 3). There was no other intraabdomi-
nal pathology noted. The medical history was notable for hyper-
tension, remote myocardial infarction, and mild renal insufficiency
with a serum creatinine level of 1.6 mg/dL. The patient had no
history of pancreatitis or abdominal trauma.
On physical examination, the patient was a well-appearing
man. The blood pressure was 140/90 mm Hg. Abdominal exam-
ination revealed a nontender, pulsatile right upper quadrant mass.
There were no abdominal bruits. The femoral and distal pulses
were normal.
The open surgical and endovascular therapeutic options were
discussed with the patient, and the minimally invasive approach
was chosen. The procedure was performed with local anesthesia
and sedation. Right femoral access was used, and the celiac artery
was selected with a 5F Simmons 2 catheter (Cook, Inc). A celiac
arteriogram showed the saccular aneurysm to be arising from the
mid portion of the common hepatic artery (CHA). The aneurysm
had a wide neck that was in close proximity to the origin of the
gastroduodenal artery. The anatomic configuration made primary
coil embolization problematic. Placement of a stent graft was
chosen to exclude the aneurysm and maintain patency of the
hepatic artery.
The patient underwent full anticoagulation with 4500 units of
intravenous heparin. The CHA was selected with a Glidewire
Fig 2. Completion arteriogram showing stent graft placement and preservation of splenic artery flow. Arrows point to
ends of stent graft.
Fig 3. Abdominal CT scan showing large hepatic artery aneu-
rysm.
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(Boston Scientific). The neck of the aneurysm was traversed with
the wire that was then advanced distally into the right/left hepatic
artery. The wire then was exchanged over a 5F Cobra GlideCath
(Boston Scientific) for an Amplatz wire (Cook, Inc). The sheath
was exchanged for a 7F Balkan sheath (Cook, Inc) that was
advanced into the CHA. The Amplatz wire was exchanged out for
a V18 Control wire (Boston Scientific). A 5-mm 26-mm Jostent
coronary stent graft (Jomed, Alpharetta, Ga) was mounted on a
5-mm  40-mm Symmetry balloon (Boston Scientific) and de-
ployed in the distal CHA. A postdeployment arteriogram through
the Balkan sheath showed continued filling of the aneurysm
through the proximal neck of the aneurysm that had remained
uncovered. A second 5-mm 26-mm Jostent was deployed prox-
imal to, but overlapping, the first. A completion arteriogram
showed complete exclusion of the aneurysm and preserved perfu-
sion through the CHA, the proper hepatic artery, and the gas-
troduodenal artery (Fig 4). The splenic and left gastric arteries were
normal. The wires and sheathes were removed, and hemostasis was
achieved with direct pressure. The patient was discharged in good
condition on the first postoperative day.
A follow-up abdominal ultrasound scan was obtained 1 month
after the procedure. The hepatic artery aneurysm was found to be
thrombosed, and there was normal flow through the CHA. The
patient continues to do well.
DISCUSSION
Visceral artery aneurysms are treated with the goal of
preventing rupture and exsanguination. The risk of aneu-
rysm rupture is determined primarily by size, although
other factors may play a role. Because of the relative rarity
and heterogeneity of these aneurysms, their exact natural
history is not known. For SAAs, which represent about 60%
of visceral artery aneurysms,4 the life-time rupture risk has
been estimated to be between 2% and 10%.5 This risk is
much higher in pregnant women6 and in patients with
portal hypertension.7 In general, a size of 2 cm or greater is
considered significant enough to warrant treatment if the
patient’s overall condition permits.8 The presence of a
symptomatic aneurysm, an aneurysm in a woman of child-
bearing age,6 or an aneurysm with documented enlarge-
ment are also indications for treatment. The overall mor-
tality rate of a ruptured SAA ranges from 10% to 25%,5,8,9
with higher rates seen in pregnant women6 and patients
with portal hypertension.10 Hepatic artery aneurysms are
the second most common visceral aneurysms, comprising
about 30% of VAAs, and aneurysms at other sites are
extremely uncommon.11 The traditional therapy of visceral
aneurysms has been surgical ligation or excision of the
aneurysm, often with attempts to preserve end-organ per-
fusion depending on the type and location of the aneurysm.
Because of the morbidity associated with a major operation,
various minimally invasive techniques have been developed.
Transcatheter embolization has been used successfully in
the treatment of splenic3 and hepatic artery12,13 aneurysms,
although end-organ ischemia, painful splenic infarction,
and late-term vessel recanalization are potential prob-
lems.14,15 Various laparoscopic techniques have also been
used with success in treating SAA.16 The use of stent grafts
in the treatment of aortic and peripheral arterial aneurysms
is well established. The application of these techniques to
visceral artery aneurysms has been recently described in two
cases.17,18 We present two additional patients treated in
this fashion with successful exclusion of the aneurysms and
preservation of end-organ flow. The arterial anatomy and
location of the aneurysm have a large impact on the tech-
nical ability to place a stent graft. There needs to be
adequate normal-caliber artery on either side of the aneu-
rysm to allow an adequate stent graft seal and complete
Fig 4. Completion celiac arteriogram showing exclusion of aneurysm by stent grafts and preserved hepatic artery
perfusion. Preserved gastroduodenal artery, along with normal splenic and left gastric arteries, are also seen. Arrows
point to ends of stent graft.
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aneurysm exclusion. Tortuosity in the visceral vessels can
also cause difficulty, but the careful use of stiff wires proved
to offer sufficient trackability. The risk of vessel rupture or
thrombosis is also a concern and could cause significant
morbidity depending on the artery affected. These factors
will limit the applicability of this technique to those patients
with favorable arterial anatomy.
In conclusion, the use of endovascular stent grafts in
the treatment of visceral artery aneurysms is a treatment
option in well-selected patients, particularly those who
would be categorized as high risk. As endovascular technol-
ogy advances, with the introduction of more flexible stent
grafts and smaller introducer systems, it may be possible to
offer this therapy to a wider population. The long-term
durability of these repairs is not known and will require
further study. For the present, these patients should be
monitored indefinitely to ensure continued aneurysm ex-
clusion. We plan to use yearly abdominal duplex scan
examinations to monitor these patients for continued arte-
rial patency, aneurysm size, and aneurysm exclusion.
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